e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program feasible in Idiopathic Pulmonary Fibrosis?
J. Cerdán de las Heras (Aarhus C, Denmark), F. Balbino (Aarhus C, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Vejle, Denmark), E. Bendstrup (Aarhus C, Denmark)
Source:
Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Session:
Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Session type:
Oral Presentation
Number:
4746
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cerdán de las Heras (Aarhus C, Denmark), F. Balbino (Aarhus C, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Vejle, Denmark), E. Bendstrup (Aarhus C, Denmark). Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program feasible in Idiopathic Pulmonary Fibrosis?. 4746
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation?
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
What can we learn from Idiopathic Pulmonary Fibrosis Registries?
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Choir in the Pulmonary Rehabilitation Program
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks
Source: Guideline 2015
Year: 2015
Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award
Source: International Congress 2015 – IPF: an airway-derived disease?
Year: 2015
Pulmonary Rehabilitation: An Interdisciplinary Approach
Source: Eur Respir J 2004; 24: 1076
Year: 2004
Epidemiology of Idiopathic Pulmonary Fibrosis in Australia
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
A Telemonitoring Homecare Platform for patients with Pulmonary Fibrosis
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary
Source: Guideline 2015
Year: 2015
Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Use of Clinical Nurse Specialists in the Management of Incidental Pulmonary Nodules
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Collaborating with stakeholders to advance the National Patient Charter for Idiopathic Pulmonary Fibrosis in Ireland.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
GPs Meet Rare Lung Disorders Task Force factsheet: cystic fibrosis
Source: Breathe 2014; 10:345-347
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept